The nerve growth factor receptor TrkA was initially isolated as a tran
sforming oncogene, trk, in which most of the extracellular receptor pa
rt is replaced by the coding sequence for a tropomyosin-encoding gene.
The impact that the identification of the first neurotrophin receptor
has made on the entire field of developmental neurobiology cannot be
overstated, Following a ! brief introduction to the biology of neurotr
ophins and their receptors, this review will focus on oncogenic Trk in
human malignant disorders, discuss putative tumorigenic involvement o
f Trk family members in the childhood malignancy neuroblastoma, and po
int out potential neurotrophin-based treatment modalities for this and
other neuroendocrine tumors.